☆ 4.6 Letter

Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study

BRITISH JOURNAL OF HAEMATOLOGY (2022)

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Volume 199, Issue 1, Pages 153-157

Publisher

WILEY

DOI: 10.1111/bjh.18349

Keywords

clinical trial; hydroxycarbamide; inflammation; sickle cell disease; vaso-occlusive crisis

Funding

Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [310717/2021-3]
Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2014/00984-3]

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6

Not enough ratings

Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Publisher

WILEY

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Safe use of hydroxycarbamide in sickle cell disease patients hospitalized for painful vaso-occlusive episodes during the randomized, open-label HELPS study

Journal

BRITISH JOURNAL OF HAEMATOLOGY

Publisher

WILEY

Keywords

Categories

Funding

Ask authors/readers for more resources

Protocol

Reagent

Authors

I am an author on this paper

Reviews

Primary Rating

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Recommended

Export Citation

Share Paper